Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK. 


Biotechnology

Education

Instil Bio

Bronson Crouch

Carol Castaneda

Artur Burgiel

Craig Kessler

T. David Chonzi

Sharon McGonagle

Film Sarah Turnbull Fcipd Fitol (Goodfellow)

Sandeep Laumas (Steve)

Robert Bob Hawkins

Mark Dudley

Sandeep Laumas

The Finance Team at Instil Bio is responsible for managing the company's financial planning, analysis, and reporting. They ensure accurate financial records, oversee budgeting and forecasting, and provide strategic financial insights to support the company’s growth and operational efficiency. This team also handles global financial compliance, tax strategy, and financial risk management to facilitate the development and commercialization of TIL cell therapies.

Finance Team

Research and Development

Board & Executive Committee

Finance Team

About

Team members

Other teams at Instil Bio

Research and Development

Board & Executive Committee